Company Filing History:
Years Active: 2024
Title: **Irene Xia: Innovator in Pharmaceutical Science**
Introduction
Irene Xia, an accomplished inventor based in Pudong, China, has made significant strides in the field of pharmaceutical science. She is the sole inventor of a notable patent focused on innovative molecules that are pivotal in combating diseases caused by kinetoplastid parasites.
Latest Patents
Irene Xia holds one patent for the creation of solid forms of N-(4-fluoro-3-(6-(3-methylpyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)phenyl)-2,4-dimethyloxazole-5-carboxamide. This patent outlines the development of fumaric acid co-crystals and X-ray amorphous complexes of Compound I, alongside methods for their production. The resulting pharmaceutical compositions show promise in treating, preventing, inhibiting, or ameliorating diseases such as leishmaniasis, human African trypanosomiasis, and Chagas disease.
Career Highlights
Irene is affiliated with Novartis AG, a leading global healthcare company. Her work contributes to the development of innovative solutions for complex health issues. This involvement positions her as a notable figure in the intersection of science and medicine.
Collaborations
Throughout her career, Irene has collaborated with talented coworkers, including Yudong Cao and Siyi Jiang. Their collective efforts foster an environment of innovation and advancement in pharmaceutical research.
Conclusion
Irene Xia exemplifies the spirit of innovation in pharmaceutical science with her significant contributions to the field. Her work not only advances medical knowledge but also holds the potential to improve the lives of many individuals suffering from serious diseases caused by kinetoplastid parasites. Her patent is a testament to the commitment and ingenuity found in the scientific community.